LiveNowLongevityPhysician-Guided Las Vegas
702-808-2650Book Your $88 Evaluation
Your evaluation$88(applied to your care)Book now
FDA status & evidence

CJC-1295 & Ipamorelin: FDA Status and Evidence

A commonly marketed growth hormone peptide pairing with no FDA-approved form. The regulatory record and the evidence for using the combination are separate questions.

Medically reviewed by Charles Kamen, MD, board-certified neurologist · ·

What the research shows

Early human studies showed a single dose of CJC-1295 raised growth hormone and IGF-1 for several days (Teichman, Journal of Clinical Endocrinology and Metabolism, 2006). It never completed development as an approved drug. Ipamorelin raises growth hormone short term but did not show clear benefit in its main surgical trial. No trial has tested the combination for health outcomes.

Both are on the World Anti-Doping Agency prohibited list.

Frequently Asked Questions

Is CJC-1295 with ipamorelin FDA-approved?

No. Neither substance is FDA-approved, alone or combined.

Can a pharmacy compound CJC-1295 and ipamorelin?

Neither is on the 503A bulks list, and ipamorelin acetate is in FDA Category 2 for 503B outsourcing facilities. Check the live FDA lists, which change.

What is an FDA-approved alternative for low growth hormone?

Diagnosed adult growth hormone deficiency is treated with FDA-approved growth hormone products after formal testing. That is a specialist decision, not a wellness protocol.

Selected Research

Peer-reviewed sources on CJC-1295 & Ipamorelin. Research does not constitute a treatment recommendation; appropriateness is determined only after a medical evaluation.

  1. Teichman SL, et al. J Clin Endocrinol Metab. 2006;91(3):799-805. (CJC-1295 produces prolonged, dose-dependent increases in GH and IGF-1 in healthy adults).
  2. Raun K, et al. Eur J Endocrinol. 1998;139(5):552-561. (Ipamorelin, selective GH secretagogue).

Compare CJC-1295 & Ipamorelin

Conditions where CJC-1295 & Ipamorelin comes up

Related Growth hormone support

MK-677 (Ibutamoren)

An oral growth hormone secretagogue studied for appetite, sleep, and body composition - physician-supervised in Las Vegas.

Tesamorelin

A GHRH analog studied for visceral fat and body composition - physician-supervised in Las Vegas.

Ipamorelin

A selective growth-hormone-releasing peptide studied for recovery and body composition - physician-supervised in Las Vegas.

GHRP-2

A growth-hormone-releasing peptide studied for body composition and recovery - physician-supervised in Las Vegas.

FDA status resources

Is CJC-1295 & Ipamorelin FDA-approved?Peptide FDA status trackerWhich peptides are FDA-approved?FDA peptide compounding statusResearch-use-only peptides explained